Cycn earnings date
WebFind Cyclerion Therapeutics Inc (CYCN) earnings date, revenues, updates and financial reports. WebMar 17, 2024 · Third quarter 2024 earnings released: US$0.24 loss per share (vs US$0.26 loss in 3Q 2024) Nov 05 Cyclerion stock tanks 32% on workforce reduction, clinical development refocus Oct 06 Consensus revenue estimates fall by 54% Aug 19 Second quarter 2024 earnings: EPS and revenues miss analyst expectations Aug 11 See more …
Cycn earnings date
Did you know?
WebApr 10, 2024 · This should be an important pivot level today. Above it, the first major target for bulls is the pre-market high of $16.80. Beyond that, the next target to the upside is teh $19.40-$20 area with $21.59 and $24 above that. Below $15.80 there is potential support at $15.30 and $14.50, $14 and $13.80 below that. WebOn Invalid Date, . Cyclerion Therapeutics (NASDAQ: CYCN) reported Q4 2024 earnings per share (EPS) of -$0.16, up 33.33% year over year. Total Cyclerion Therapeutics earnings for the quarter were -$7.22 million.In the same quarter last year, Cyclerion Therapeutics's earnings per share (EPS) was -$0.24.
WebCYCN Cyclerion Therapeutics Inc 4,435 Watch $0.3283 $0.0183 (5.90%) Today $0.00 0.00 (0.00%) After Hours Market Cap $14.29M Volume (M) 312,352.00 52-Wk High $1.25 52-Wk Low $0.3007 About Feed Sentiment Fundamentals News There is no chart data available for this period 1d 1w 1m 3m 6m 1y All Sentiment Message Volume WebMar 10, 2024 · CYCN Cyclerion Therapeutics, Inc. Earnings Summary Earnings Estimates Earnings Revisions Earnings Surprise Latest Quarter's Earnings Upcoming Quarter's …
WebThe latest price target for Cyclerion Therapeutics ( NASDAQ: CYCN) was reported by Truist Securities on October 20, 2024. The analyst firm set a price target for $14.00 expecting CYCN to rise... WebCyclerion Therapeutics, Inc. (CYCN) Latest Stock News & Headlines - Yahoo Finance Watchlists My Portfolio Crypto Yahoo Finance Plus Videos S&P 500 Dow 30 …
WebEarnings: The amount and date of latest Earnings Per Share (EPS) paid out to shareholders. Dividend: Annual dividend, or portion of a company's profit paid to …
WebMar 17, 2024 · Stable Share Price: CYCN is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 17% a week. Volatility Over Time: CYCN's weekly … fa design székekWebCyclerion Therapeutics (CYCN) Earnings Date & Reports 144 Followers Portfolio Earnings Data Report Date May 02, 2024 Not Confirmed Period Ending 2024 (Q1) Consensus … hiperplasia senilWebJul 1, 2024 · Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on insider trading activity, which can give hints on whether executives are bullish or bearish on their own companies. hiperplasia submandibularWebApr 3, 2024 · Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2024. Do the … hiperplasia sinusoidalWebGet the latest Cyclerion Therapeutics earnings report, revenues and EPS as well as upcoming CYCN earnings dates. hiperplasia suprarrenal bilateral causasWebMar 27, 2024 · Detailed statistics for Cyclerion Therapeutics, Inc. (CYCN) stock, including valuation metrics, financial numbers, share information and more. ... Estimated Earnings Date May 3, 2024: Ex-Dividend Date n/a: Share Statistics. CYCN has 43.52 million shares outstanding. The number of shares has increased by 11.05% in one year. faden amazonWebFind the latest dividend history for Cyclerion Therapeutics, Inc. Common Stock (CYCN) at Nasdaq.com. Cyclerion Therapeutics, Inc. Common Stock (CYCN) Dividend History … hiperplasia simple